Autopsy report · NCT00157261
Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial
Cause of deathNo reason given
Life of this trial
- Registered 1 year 8 months after it had already started.
- Ran for about 2 years 5 months before it stopped.
- 1,050 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry
- Conditions
- Heart Arrest
- Interventions
- tenecteplase
- Participants
- 1,050
- Sites
- 68
- Countries
- Austria, Belgium, France, Germany, Italy, Norway, Spain, Sweden, Switzerland
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.